Peritoneal cell response during adhesion formation

Journal of Investigative Surgery

Volumn 23, Issue 5, 2010, Pages 267-272

  Adam, Hermanowicz ^a   Wojciech, Debek ^a   Marzanna, Oksiuta ^a   Ewa, Matuszczak ^a   Ewa, Dzienis Koronkiewicz ^a   Lech, Chyczewski ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Mast cells; Peritoneal adhesions; Peritoneal fluid; Peritoneum

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; CELL ADHESION; CELL COUNT; CELL FUNCTION; CELL POPULATION; CONTROLLED STUDY; FEMALE; LAPAROTOMY; MAST CELL; NEUTROPHIL; NONHUMAN; PERITONEAL FLUID; PERITONEUM ADHESION; PERITONEUM CELL; PRIORITY JOURNAL; RAT; REOPERATION; SEROSA; WISTAR RAT;

ANIMALS; ASCITIC FLUID; CELL COUNT; CYTOKINES; EOSINOPHILS; FEMALE; LYMPHOCYTES; MACROPHAGES; MAST CELLS; PERITONEAL DISEASES; POSTOPERATIVE COMPLICATIONS; RATS; RATS, WISTAR; TISSUE ADHESIONS;

EID: 77957348955     PISSN: 08941939     EISSN: 15210553     Source Type: Journal    
DOI: 10.3109/08941939.2010.496035     Document Type: Article

References (30)

1. Thomson J. Pathogenesis and prevention of adhesion formation. Dig Surg. 1998;15:153-157.
2. DiZerega GS, Campeau JD. Peritoneal repair and post-surgical adhesion formation. Human Rep Update 2001;7:547-555.
3. Milligan DW, Rafter AT. Observations on the pathogenesis of peritoneal adhesions: a light and electron microscopical study. BJ Surg. 1974;61:274.
4. Langer JC, Liebman SM, Monk PK. Mast cell mediators and peritoneal adhesion formation in the rat. J Surg Res. 1995;59:344-348.
5. Ruger B, Dunbar PR, Hasan Q. Human mast cells produce type VIII collagen in vivo. Int J Exp Pathol. 1994;75:397-404.
6. Tompson HL, Burbelo PD, Gabriel G, et al. Murine mast cells synthesize basement membrane components: a potential role of early fibrosis. J Clin Invest. 1991;87:619-623.
7. Cahill RA, Wang JH, Soohkai S, et al. Mast cells facilitate local VEGF release as an early event in the pathogenesis of postoperative peritoneal adhesions. Surgery 2006;140:108-112.
8. Hulka J, Omran K, Berger G. Classification of adnexal adhesions: a proposal and evaluation of its prognostic value. Fertil Steril. 1978;30:661-665.
9. Haney A. Identification of macrophages at the site of peritoneal injury: evidence supporting a direct role for peritoneal macrophages in healing injured peritoneum. Fertil Steril. 2000;73:988-995.
10. Olive D, Haney A, Weinberg J. The nature of exudates associated with infertility: peritoneal fluid and serum lyzosome. Fertil Steril. 1987;48:802-806.
11. Haney AF, Doty E. The formation of coalescing peritoneal adhesions requires injury to both contacting peritoneal surfaces. Fertil Steril. 1994;61:767-775.
12. diZerega GS. Use of Adhesion Barriers in Pelvic Reconstructive and Gynecology Surgery. New York: Springer; 2000:379-399.
13. Raftery AT. Regeneration of parietal and visceral peritoneum: an electron microscopical study. J Anat. 1973;115:375-392.
14. Cheong YC, Laird SM, Li TC, et al. Peritoneal healing and adhesion formation/reformation. Human Rep Update 2001;7:556-566.
15. Zareie M, Fabbrini P, Hekking LHP, et al. Novel role for mast cells in omental tissue remodeling and cell recruitment in experimental peritoneal dialysis. J Am Soc Nephrol. 2006;17:3447-3457.
16. Harris ES, Morgan RF, Rodeheaver GT. Analysis of the kinetics of peritoneal adhesion formation in the rat and evaluation of potential antiadhesive agents. Surgery 1995;117:663-669.
17. Xu X, Pappo O, Garbuzenko E, et al. Mast cell dynamics and involvement in the development of peritoneal adhesions in the rat. Live Sci. 2002;70:951-967. (Pubitemid 34075599)
18. Holdmahl L. The plasmin system, a marker of the propensity to develop adhesions. In: Peritoneal Surgery. New York: Springer; 2000:117-132.
19. Thompson J. Peritoneal fibrynolysis and adhesion formation. In: diZerega Peritoneal Surgery. New York: Springer; 2000:133-142.
20. Brauner A, Hylander B, Wretlind B. TNF-alpha, IL-1beta and IL-1 receptor antagonist in dialysate and serum from patients on CAPD. Am J Kidney Dis. 1996;27:402-408.
21. Lowry S. Cytokines mediators of immunity and inflammation. Arch Surg. 1993;128:1235-1241.
22. Mori H, Sawairi M, Nakagawa M. Peritoneal fluid IL-1 beta and TNF in patients with benign gynaecological disease. Am J Reprod Immun. 1991;26:62-67.
23. Ivarsson M, Holmdahl L, Falk P. Characterization and fi-brynolytic properties of mesothelial cells isolated from peritoneal lavage. Scand J Clin Lab Invest. 1998;58:195-203.
24. Tietze L, Elbreht A, Schauerte C. Modulation of pro and antifibrinolytic properties of human peritoneal mesothelial cells by transforming growth factor beta1, tumor necrosis factor alpha and interleukin 1beta. Thromb Haemost. 1998;79: 362-370.
25. Metcalfe D, Baram D, Mekori Y. Mast cells. Physiol Rev. 1997;77:1033-1079.
26. Wedemeyer J, Tsai M, Galli SJ. Roles of mast cells and ba-sophils in innate and acquired immunity. Curr Opin Immunol. 2000;12:624-631.
27. Levi-Schaffer F. Mast cell/fibroblast interactions in health and disease. Chem Immunol. 1995;61:161-185.
28. Norrby K. Evidence of mast cell histamine being mitogenic in intact tissue. Agents Actions. 1985;16:287-290.
29. Kupietzky A, Levi-Schaffer F. The role of mast cell-derived histamine in the closure of an in vitro wound. Inflamm Res. 1996;45:176-180.
30. Gruber BL, Kew RR, Jelaska A, et al. Human mast cells activate fibroblasts: tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis. J Immunol. 1997;158:2310-2317.